PRTCPuretech Health
Mkt Cap
$345.62MVolume
1,542.0052W High
$24.9952W Low
$13.30PE Ratio
9.33PRTC Fundamentals
Price
$17.00Prev Close
$17.75Open
$17.5050D MA
$17.37Beta
0.29Avg. Volume
5,770.52EPS (Annual)
$2.10P/B
1.09PureTech Presents New Phase 2b Analyses Demonstrating Consistent Safety and Efficacy of Deupirfenidone in Older Patients with Idiopathic Pulmonary Fibrosis (IPF), a Historically Undertreated Group
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today...
Business Wire·9d ago
What Makes PureTech Health (PRTC) a New Buy Stock
PureTech Health (PRTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·1mo ago
PureTech to Present at the Leerink Partners Global Healthcare Conference
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...
Business Wire·8mo ago
PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that...
Business Wire·9mo ago
PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...
Business Wire·10mo ago
PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...
Business Wire·10mo ago
PureTech Appoints UBS as UK Corporate Broker
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), is pleased to announce that it has appointed UBS as its UK Corporate Broker. About PureTech Health PureTech is a...
Business Wire·10mo ago
PureTechs Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...
Business Wire·11mo ago
PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, (Seaport) a clinical-stage...
Business Wire·11mo ago
PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, presented data...
Business Wire·11mo ago